PFG Private Wealth Management’s Cytokinetics CYTK Stock Holding History

PFG Private Wealth Management’s Portfolio CYTK Stock Details CYTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-240	Closed	-$9.65K	–	102
2025 Q1	$9.65K	Hold	240	–	–	0.01%	155
2024 Q4	$11.3K	Hold	240	–	–	0.01%	131
2024 Q3	$12.7K	Hold	240	–	–	0.01%	134
2024 Q2	$13K	Hold	240	–	–	0.01%	131
2024 Q1	$16.8K	Hold	240	–	–	0.01%	114
2023 Q4	$20K	Hold	240	–	–	0.01%	104
2023 Q3	$7.07K	Hold	240	–	–	0.01%	200
2023 Q2	$7.83K	Hold	240	–	–	﹤0.01%	221
2023 Q1	$8.45K	Hold	240	–	–	0.01%	212
2022 Q4	$11K	Hold	240	–	–	0.01%	183
2022 Q3	$12K	Hold	240	–	–	0.01%	172
2022 Q2	$9K	Buy	+240	New	+$9.66K	0.01%	199

Other funds holding CYTK

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

PFG Private Wealth Management's CYTK Position: Q2 2025 in Review

PFG Private Wealth Management sold out of Cytokinetics (CYTK) in Q2 2025, closing a stake of 240 shares — an estimated $9.65K sold.

PFG Private Wealth Management first reported a position in CYTK in Q2 2022 and held it in 12 quarters. The position peaked at $20K in Q4 2023. 311 funds tracked by Wall St. Rank hold CYTK as of Q2 2025.

PFG Private Wealth Management reported no remaining Cytokinetics position as of Q2 2025 after selling out during the quarter.
PFG Private Wealth Management sold 240 Cytokinetics shares in Q2 2025, an estimated $9.65K.
PFG Private Wealth Management first reported a position in Cytokinetics in Q2 2022 and held it in 12 quarters.
PFG Private Wealth Management's Cytokinetics position peaked at $20K in Q4 2023.
311 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2025.

Based on PFG Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.